Zenas Technologies is a contract research organization providing accurate, predictive assays and in-depth, expert analysis.

Zenas Technologies has screened thousands of compounds against a variety of cardiac ion channels.

Our unique ion channel assays featuring the use of native human cardiac myocytes and our hERG assays are conducted under physiological condition and with the results presented in physiologically meaningful manner. Building on our cardiovascular expertise, Zenas Technologies is one of the few CROs also offering central nervous system assays to help clients advance their chronic neuropathic pain development programs.

Zenas focuses on client care and collaboration offering comprehensive protocol design, technical oversight and consulting to propel your projects further through the testing funnel.


Our proven cardiac and CNS data packages, nuanced interpretations and consulting services help our clients make key decisions on leading drug candidates early in the development process—saving time, money and